Stek advises Abacus on its acquisition of Pluripharm

Danish pharmaceutical supplier Abacus Medicine A/S has acquired Dutch pharmaceutical wholesaler Pluripharm Group. The group is one of four leading pharmaceutical wholesalers in the Netherlands with a full line of medicines, medical devices and services. Stek advised on the acquisition including the merger control proceeding before the Dutch Competition Authority.

Please click here for the press release.

This might also interest you

Stek successful for Liander in transport capacity dispute

Stek advises Egeria on its intended acquisition of IT-company Superp

Stek advises Stedin on EUR 500 million equity investment by the Dutch State.